PROGRAM CHAIR
Andrew J. Armstrong, MD, MSc
Professor of Medicine, Division of Medical Oncology
Duke Cancer Institute
Duke University
Durham, NC
FACULTY PRESENTER
Matthew Labriola, MD
Assistant Professor of Medicine, Division of Medical Oncology
Duke Cancer Institute
Duke University
Durham, NC
PROGRAM OVERVIEW
This series of podcasts will provide healthcare professionals with valuable information aimed at improving the standard of care for patients with metastatic hormone-sensitive prostate cancer (mHSPC). In this series of succinct, engaging podcasts, experts discuss the latest evidence-based guideline recommendations, multidisciplinary care approaches, and strategies to improve shared decision making and access to equitable care for patients with mHSPC.
TARGET AUDIENCE
This activity is designed to meet the educational needs of U.S.-based healthcare professionals responsible for the treatment decisions for patients with prostate cancer, including urologists, medical oncologists, and radiation oncologists.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Improve quality of care for patients with mHSPC using evidence-based guideline-recommendations
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIP(S)
| Faculty Member | Disclosures |
| Andrew J. Armstrong, MD, MSc | Discloses that he has received consulting fees from Bayer, Janssen, Astellas, Pfizer, AstraZeneca, Merck, Bristol Myers Squibb, Novartis, Forma, Exelixis, Myovant, Dendreon, and received funds for contracted research from Bayer, Janssen, Astellas, Pfizer, AstraZeneca, Merck, BMS, Novartis, Forma. |
| Matthew Labriola, MD | Has no relevant financial relationships to disclose. |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Kia Jones, PhD, Medical Director for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Victoria Zeitz, Program Manager for Med Learning Group, has nothing to disclose.
- Daniel Dasilva, Accreditation and Outcomes Coordinator, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this activity.
In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation.
Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science based.
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
Please listen to the podcast below:
RELEASED DATE: November 17, 2023
EXPIRATION DATE: November 17, 2024
Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
PROGRAM CHAIR
Andrew J. Armstrong, MD, MSc
Professor of Medicine, Division of Medical Oncology
Duke Cancer Institute
Duke University
Durham, NC
FACULTY PRESENTER
Ryan Fecteau, MD, PhD
Medical Instructor, Department of Radiation Oncology
Duke University
Durham, NC
PROGRAM OVERVIEW
This series of podcasts will provide healthcare professionals with valuable information aimed at improving the standard of care for patients with metastatic hormone-sensitive prostate cancer (mHSPC). In this series of succinct, engaging podcasts, experts discuss the latest evidence-based guideline recommendations, multidisciplinary care approaches, and strategies to improve shared decision making and access to equitable care for patients with mHSPC.
TARGET AUDIENCE
This activity is designed to meet the educational needs of U.S.-based healthcare professionals responsible for the treatment decisions for patients with prostate cancer, including urologists, medical oncologists, and radiation oncologists.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Incorporate a multidisciplinary care team-based approach that includes shared decision-making to promote treatment adherence and other outcomes for patients with mHSPC
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIP(S)
| Faculty Member | Disclosures |
| Andrew J. Armstrong, MD, MSc | Discloses that he has received consulting fees from Bayer, Janssen, Astellas, Pfizer, AstraZeneca, Merck, Bristol Myers Squibb, Novartis, Forma, Exelixis, Myovant, Dendreon, and received funds for contracted research from Bayer, Janssen, Astellas, Pfizer, AstraZeneca, Merck, BMS, Novartis, Forma. |
| Ryan Fecteau, MD, PhD | Discloses that he has received consulting fees from Veracyte/Decipher Biosciences. |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Kia Jones, PhD, Medical Director for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Victoria Zeitz, Program Manager for Med Learning Group, has nothing to disclose.
- Daniel Dasilva, Accreditation and Outcomes Coordinator, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this activity.
In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation.
Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
Please listen to the podcast below:
RELEASED DATE: November 17, 2023
EXPIRATION DATE: November 17, 2024
Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
PROGRAM CHAIR
Andrew J. Armstrong, MD, MSc
Professor of Medicine, Division of Medical Oncology
Duke Cancer Institute
Duke University
Durham, NC
FACULTY PRESENTER
Hannah Dzimitrowicz McManus, MD
Assistant Professor of Medicine, Division of Medical Oncology
Duke Cancer Institute
Duke University
Durham, NC
PROGRAM OVERVIEW
This series of podcasts will provide healthcare professionals with valuable information aimed at improving the standard of care for patients with metastatic hormone-sensitive prostate cancer (mHSPC). In this series of succinct, engaging podcasts, experts discuss the latest evidence-based guideline recommendations, multidisciplinary care approaches, and strategies to improve shared decision making and access to equitable care for patients with mHSPC.
TARGET AUDIENCE
This activity is designed to meet the educational needs of U.S.-based healthcare professionals responsible for the treatment decisions for patients with prostate cancer, including urologists, medical oncologists, and radiation oncologists.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Improve quality of care for patients with mHSPC using evidence-based guideline-recommendations
- Support equitable care for those with mHSPC through improved access to novel hormonal therapies
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIP(S)
| Faculty Member | Disclosures |
| Andrew J. Armstrong, MD, MSc | Discloses that he has received consulting fees from Bayer, Janssen, Astellas, Pfizer, AstraZeneca, Merck, Bristol Myers Squibb, Novartis, Forma, Exelixis, Myovant, Dendreon, and received funds for contracted research from Bayer, Janssen, Astellas, Pfizer, AstraZeneca, Merck, BMS, Novartis, Forma. |
| Hannah Dzimitrowicz McManus, MD | Has no relevant financial relationships to disclose. |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Kia Jones, PhD, Medical Director for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Victoria Zeitz, Program Manager for Med Learning Group, has nothing to disclose.
- Daniel Dasilva, Accreditation and Outcomes Coordinator, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this activity.
In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation.
Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
Please listen to the podcast below:
RELEASED DATE: November 17, 2023
EXPIRATION DATE: November 17, 2024
Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
